β-Lapachone, a substrate of NAD(P)H:Quinone oxidoreductase, induces anti-inflammatory heme oxygenase-1 via AMP-activated protein kinase activation in RAW264.7 macrophages

Journal of Clinical Biochemistry and Nutrition

Volumn 52, Issue 2, 2013, Pages 106-111

  Byun, Seung Jae ^a   Son, Young ^a   Cho, Baik Hwan ^b   Chung, Hun Taeg ^c   Pae, Hyun Ock ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c University of Ulsan   (South Korea)

Author keywords

Lapachone; AMP activated protein kinase; Heme oxygenase 1; Inducible nitric oxide synthase; Tumor necrosis factor a

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE 1 BETA DEXTRO RIBOFURANOSIDE; BETA LAPACHONE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTOPORPHYRIN TIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MACROPHAGE; PROTEIN EXPRESSION;

EID: 84875884326     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-80     Document Type: Article

References (26)

1. Carling D, Thornton C, Woods A, Sanders MJ. AMP-activated protein kinase: new regulation, new roles. Biochem J 2012; 445: 11-27.
2. Fisslhaler B, Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 2009; 105: 114-127.
3. Leverve XM, Guigas B, Detaille D, et al. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab 2003; 29: 6S88-6S94. (Pubitemid 37187095)
4. Hawley SA, Ross FA, Chevtzoff C, et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 2010; 11:554-565.
5. Katerelos M, Mudge SJ, Stapleton D, et al. 5-aminoimidazole-4-carbox- amide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB. Immunol Cell Biol 2010; 88: 754-760.
6. Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ, Lai LP. Metformin inhibits TNF-a-induced IkB kinase phosphorylation, IκB-α degradation and IL-6 production in endothelial cells through P13K-dependent AMPK phosphorylation.Int. J Cardiol 2009; 134: 169-175.
7. Tsoyi K, Jang HJ, Nizamutdinova IT, et al. Metformin inhibits HMGBl release in LPS-treated RAW264.7 cells and increases survival rate of endotoxaemic mice. Br. J Pharmacol 2011; 162: 1498-1508.
8. Jeong HW, Hsu KC, Lee JW, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Melab 2009; 296: E955-E964.
9. Liu XM, Peyton KJ, Shebib AR, et al. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 2011; 300: H84-H93.
10. Wang JS, Ho FM, Kang HC, Lin WW, Huang KC. Celecoxib induces heme oxygenase-1 expression in macrophages and vascular smooth muscle cells via ROS-dependent signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 2011; 383: 159-168.
11. Kim HP, Pae HO, Back SH, et al. Heme oxygenase-1 comes back to endoplasmic reticulum. Biochem Biophys Res Commun 2011; 404: 1-5.
12. Pae HO, Lee YC, Jo EK, Chung HT. Subtle interplay of endogenous bio-active gases (NO, CO and H2S) in inflammation. Arch Pharm Res 2009; 32: 1155-1162.
13. Siegel D, Yan C, Ross D. NAD(P)H:quinone oxidoreductase 1 (NQOl) in the sensitivity and resistance to antitumor quiñones. Biochem Pharmacol 2012; 83: 1033-1040.
14. Bae JH, Kim JW, Kweon GR, et al. Corpus cavemosal smooth muscle relaxation effect of a novel AMPK activator, p-lapachone. J Sex Med 2011; 8: 2205-2214.
15. Kim SY, Jeoung NH, Oh CJ, et al. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ Res 2009; 104: 842-850.
16. Kim YH, Hwang JH, Noh JR, et al. Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity. Cardiovasc Res 2011; 91: 519-527.
17. Hwang JH, Kim DW, Jo EJ, et al. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 2009; 58: 965-974.
18. Tzeng HP, Ho FM, Chao KF, Kuo ML, Lin-Shiau SY, Liu SH. β-Lapachone reduces endotoxin-induced macrophage activation and lung edema and mortality. Am. J Respir Crit Care Med 2003; 68: 85-91.
19. Xue B, Kahn BB. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 2006; 574: 73-83. (Pubitemid 43905798)
20. Cai Y, Martens GA, Hinke SA, Heimberg H, Pipeleers D, Van de Casteele M. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Free Radic Biol Med 2007; 42: 64-78. (Pubitemid 44839152)
21. Murakami A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr 2009; 61: 193-203.
22. Conforti F, Menichini F. Phenolic compounds from plants as nitric oxide production inhibitors. Curr Med Chem 2011; 18: 1137-1145.
23. Pillai VB, Sundaresan NR, Kim G, et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LκBl-AMP-activated kinase pathway. J Biol Chem 2010; 285: 3133-3144.
24. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SlRTl through AMPK-mediated regulation of Nampt. Dev Cell 2008; 14: 661-673. (Pubitemid 351622608)
25. Ying W. NAD* and NADH in cellular functions and cell death. Front Biosci 2006; 11:3129-3148. (Pubitemid 43800402)
26. Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007; 47: 185-210.